Warfarin Dose Prediction (PG 1639, 1075, 0430)

DNA Genetic Tests

Product Feature

• Required only hours from blood sample to results.
• Designed for easy operation & analysis.
• Validated accuracy with 400+ patients samples* & DNA sequencing.
• Protected by US, Europe & world wide patents.

Detection

VKORC1 (-1639) Detection:

RT-PCR & TaqMan® based detection method: each sample requires only 1 PCR rxns for surveying of relevant subtypes of VKORC1 (-1639). GG, GA, & AA subtypes controls are developed to establish the position of GG, GA, & AA subtypes for analysis. Analysis is based on the position of the test sample verses the positions of each subtypes. A complete kit version is CE marked and has IVD approval from Department of Health, Taiwan.

CYP2C9*2 Detection:

RT-PCR & TaqMan® based detection method: each sample requires only 1 PCR rxns for surveying of relevant subtypes of CYP2C9*2 (c.430). CC, CT, & TT subtypes controls are developed to establish the position of CC, CT, & TT subtypes for analysis. Analysis is based on the position of the test sample verses the positions of each subtypes. A complete kit version is CE marked and has IVD approval from Department of Health, Taiwan.

CYP2C9*3 Detection:

RT-PCR & TaqMan® based detection method: each sample requires only 1 PCR rxns for surveying of relevant subtypes of CYP2C9*3 (c.1075). AA, AC, & CC subtypes controls are developed to establish the position of AA, AC, & CC subtypes for analysis. Analysis is based on the position of the test sample verses the positions of each subtypes.A complete kit version is CE marked and has IVD approval from Department of Health, Taiwan.